SciELO - Scientific Electronic Library Online

 
vol.28 suppl.1The value of repeat kidney biopsy in lupus nephritis. A systematic reviewOrgan damage in systemic lupus erythematosus índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Reumatología

versão impressa ISSN 0121-8123

Resumo

ZAMORA-MEDINA, María del Carmen; OROZCO-GUILLEN, Oralia Alejandra; DOMINGUEZ-QUINTANA, Maricruz  e  ROMERO-DIAZ, Juanita. Systemic lupus erythematosus and pregnancy: Strategies before, during and after pregnancy to improve outcomes. Rev.Colomb.Reumatol. [online]. 2021, vol.28, suppl.1, pp.53-65.  Epub 21-Fev-2022. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2021.03.004.

Systemic lupus erythematosus is a multisystemic autoimmune disorder that predominantly affects women in reproductive years. Pregnancy in women with SLE is still considered a high-risk condition although several strategies may improve maternal and fetal outcomes. Preconception counseling is fundamental and should include identification of risk factors for adverse pregnancy outcomes, explanation of potential maternal and obstetric complications and timely planning of pregnancy. Risk stratification must consider end-organ damage, comorbidities, disease activity and autoantibodies profile in order to implement an individual-risk pregnancy monitoring plan by a multidisciplinary team. Hydroxychloroquine and low dose aspirin have shown to lower the risk of disease flares and preeclampsia with a good safety profile, so its use during pregnancy in all SLE patients is recommended. Lupus nephritis and preeclampsia share clinical and laboratory features hindering differentiation between both entities. Novel angiogenic markers and fetal ultrasound findings could be helpful in the differential diagnosis, especially after 20 weeks of gestation. Antiphospholipid antibodies, particularly lupus anticoagulant, are closely associated with obstetric complications. Therapy with low dose aspirin and heparin, according to risk profile, may improve live birth rates. Anti-Ro/La antibodies confer risk for neonatal lupus, and therefore preventive therapy and special fetal surveillance should be instituted.

Palavras-chave : Lupus erythematosus; Systemic; Pregnancy; Neonatal systemic lupus erythematosus; Lupus nephritis; Antibodies; Antiphospholipid.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )